SCHEMBL4874422

SCHEMBL4874422

O=C(CN1CCN(C(=O)c2ccccc2)CC1)c1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.66
MEN1 O00255 3/20 0.66
ALDH1A1 P00352 4/20 0.66
KDM4E B2RXH2 2/20 0.62
KCNH2 Q12809 1/20 0.62
BLM P54132 1/20 0.58
HPGD P15428 1/20 0.58
LMNA P02545 3/20 0.57
MAPK1 P28482 2/20 0.57
SIGMAR1 Q99720 1/20 0.57
KCNA5 P22460 1/20 0.57
DRD2 P14416 1/20 0.57
HTR2A P28223 1/20 0.57
RAB9A P51151 1/20 0.57
TSHR P16473 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
USP2 O75604 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4875267 0.89 ALDH1A1 (0.79) KMT2AMEN1ALDH1A1KDM4EKCNH2
SCHEMBL3074396 0.88 MEN1 (0.68) KMT2AMEN1ALDH1A1KDM4EKCNH2
SCHEMBL4874442 0.86 POLB (0.71) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL27943670 0.85 MEN1 (0.64) KMT2AMEN1ALDH1A1KDM4EKCNH2
SCHEMBL3688168 0.85 MEN1 (0.64) KMT2AMEN1ALDH1A1KDM4EKCNH2
SCHEMBL28135954 0.85 MEN1 (0.64) KMT2AMEN1ALDH1A1KDM4EKCNH2
SCHEMBL10432577 0.85 ALDH1A1 (0.70) KMT2AMEN1ALDH1A1KDM4ELMNA
SCHEMBL21044195 0.84 ALDH1A1 (0.72) KMT2AMEN1ALDH1A1KCNH2MAPK1
SCHEMBL17549668 0.83 KMT2A (0.84) KMT2AMEN1ALDH1A1KCNH2SIGMAR1
SCHEMBL252026 0.83 HPGD (0.79) KMT2AMEN1ALDH1A1KDM4EKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7326710-B2 Aralkyl formyl-alkyl piperazine derivatives and their uses as a cerebral nerve protective agent SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) 2008-02-05 US claimed
US-20050153981-A1 Aralkyl formly-alkyl piperazine derivatives and their uses as a cerebral nerve protective agent SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) 2005-07-14 US claimed
EP-1553092-A1 ARALKYL FORMYL-ALKYL PIPERAZINE DERIVATIVES AND THEIR USES AS CEREBRAL NERVE PROTECTIVE AGENT Shanghai Institute of Pharmaceutical Industry (CN) 2005-07-13 EP claimed
US-7326710-B2 Aralkyl formyl-alkyl piperazine derivatives and their uses as a cerebral nerve protective agent SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) 2008-02-05 US disclosed
US-20050153981-A1 Aralkyl formly-alkyl piperazine derivatives and their uses as a cerebral nerve protective agent SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) 2005-07-14 US disclosed
EP-1553092-A1 ARALKYL FORMYL-ALKYL PIPERAZINE DERIVATIVES AND THEIR USES AS CEREBRAL NERVE PROTECTIVE AGENT Shanghai Institute of Pharmaceutical Industry (CN) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050153981-A1 Aralkyl formly-alkyl piperazine derivatives and their uses as a cerebral nerve protective agent GAP43, FABP7, AGK KMT2A 3987/4885MEN1 4248/4885ALDH1A1 1828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.